The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-carbamimidoylbenzyl)-N,N'-bis(4-carbamimidoylphenethyl)methanetricarboxamide ID: ALA5282514
Max Phase: Preclinical
Molecular Formula: C30H35N9O3
Molecular Weight: 569.67
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)c1ccc(CCNC(=O)C(C(=O)NCCc2ccc(C(=N)N)cc2)C(=O)NCc2ccc(C(=N)N)cc2)cc1
Standard InChI: InChI=1S/C30H35N9O3/c31-25(32)21-7-1-18(2-8-21)13-15-37-28(40)24(30(42)39-17-20-5-11-23(12-6-20)27(35)36)29(41)38-16-14-19-3-9-22(10-4-19)26(33)34/h1-12,24H,13-17H2,(H3,31,32)(H3,33,34)(H3,35,36)(H,37,40)(H,38,41)(H,39,42)
Standard InChI Key: MGUFOKPCSWNPHO-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 44 0 0 0 0 0 0 0 0999 V2000
-5.0003 2.2680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2857 2.6803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5739 2.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5739 1.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2839 1.0315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0003 1.4396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8592 1.0306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1446 1.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4300 1.0306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7153 1.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0006 1.0306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7153 2.2684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7138 1.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4285 1.0306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7138 2.2684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1432 1.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8577 1.0306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5724 1.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5726 2.2685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2855 2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0004 2.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0019 1.4454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2901 1.0289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7150 2.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7150 3.5043 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4296 2.2665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7150 2.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4296 2.2680 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7150 3.5058 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0006 0.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7138 -0.2071 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7153 -0.2071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7153 -1.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4300 -1.4448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4302 -2.2701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1431 -2.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8579 -2.2681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8595 -1.4470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1476 -1.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5725 -2.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5725 -3.5058 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2872 -2.2681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 1 0
17 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
21 24 1 0
24 25 2 0
24 26 1 0
1 27 1 0
27 28 1 0
27 29 2 0
11 30 1 0
30 31 2 0
30 32 1 0
32 33 1 0
33 34 1 0
35 34 2 0
36 35 1 0
37 36 2 0
38 37 1 0
39 38 2 0
34 39 1 0
37 40 1 0
40 41 1 0
40 42 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 569.67Molecular Weight (Monoisotopic): 569.2863AlogP: 0.49#Rotatable Bonds: 14Polar Surface Area: 236.91Molecular Species: BASEHBA: 6HBD: 9#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 12#RO5 Violations (Lipinski): 3CX Acidic pKa: 10.34CX Basic pKa: 11.98CX LogP: -1.02CX LogD: -7.04Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.08Np Likeness Score: -0.28
References 1. Hammerschmidt SJ, Maus H, Weldert AC, Gütschow M, Kersten C.. (2023) Improving binding entropy by higher ligand symmetry? - A case study with human matriptase., 14 (5): [PMID:37252099 ] [10.1039/d3md00125c ]